Active energy ray curable composition and cured product
The formulation of (meth)acrylates with an alicyclic skeleton, N-substituted (meth)acrylamides, and urethane group-containing (meth)acrylates addresses the bending resistance issue in flexible displays by providing a cured product with high elongation and elastic modulus.
Patent Information
- Application Number
- JP2021015353
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-02-05
- Filing Date
- 2021-02-02
- Publication Date
- 2024-12-09
- Estimated Expiration
- 2041-02-02
AI Technical Summary
Conventional active energy ray-curable compositions have insufficient bending resistance, requiring high elongation and high elastic modulus to meet the needs of flexible displays, which they fail to achieve.
A composition comprising (meth)acrylates with an alicyclic skeleton, N-substituted (meth)acrylamides, and monofunctional (meth)acrylates with linear or branched alkyl groups, along with a urethane group-containing (meth)acrylate and a photopolymerization initiator, formulated to provide high elongation and elastic modulus.
The composition achieves low viscosity with a cured product that exhibits high elongation and elastic modulus, suitable for flexible displays.
Smart Images

Figure 0007596164000001
Abstract
Description
[Technical field]
[0001] The present invention relates to an active energy ray-curable composition and a cured product thereof. [Background technology]
[0002] 2. Description of the Related Art Cured products of active energy ray-curable compositions have been used as materials for displays such as organic EL displays (see, for example, Patent Documents 1 and 2). In recent years, so-called flexible displays that can be folded have been developed as such displays, and as a result, materials for such displays are required to have bending resistance that prevents the displays from being damaged when folded. However, cured products of conventional active energy ray-curable compositions have insufficient bending resistance, and in order to achieve sufficient bending resistance, it has been necessary to achieve both high elongation and high elastic modulus at high levels. [Prior art documents] [Patent documents]
[0003] [Patent Document 1] JP 2013-133427 A [Patent Document 2] JP 2012-194212 A Summary of the Invention [Problem to be solved by the invention]
[0004] An object of the present invention is to provide an active energy ray-curable composition which has a low viscosity and gives a cured product which is capable of simultaneously achieving high levels of both high elongation and high elastic modulus. [Means for solving the problem]
[0005] The present inventors conducted extensive research to solve the above problems and arrived at the present invention. That is, the present invention provides an active energy ray-curable composition comprising (A) a (meth)acrylate having an alicyclic skeleton, (B) an N-substituted (meth)acrylamide, (C) a monofunctional (meth)acrylate having a linear or branched alkyl group having 8 to 18 carbon atoms, (D) a (meth)acrylate having a urethane group, and (E) a photopolymerization initiator, The (meth)acrylate (D) having a urethane group contains polyol (a), polyisocyanate (b) and active hydrogen group-containing (meth)acrylate (c) as constituent materials. Contains 1 to 2 (meth)acryloyl groups It is a urethane (meth)acrylate, an active energy ray-curable composition, the active energy ray-curable composition comprising, based on the total weight of the (meth)acrylate having an alicyclic skeleton (A), the N-substituted (meth)acrylamide (B), the monofunctional (meth)acrylate having a linear or branched alkyl group having 8 to 18 carbon atoms (C), and the (meth)acrylate having a urethane group (D), the active energy ray-curable composition being 20% by weight to 70% by weight of the (meth)acrylate having an alicyclic skeleton (A), 10% by weight to 40% by weight of the N-substituted (meth)acrylamide (B), 2% by weight to 20% by weight of the monofunctional (meth)acrylate having a linear or branched alkyl group having 8 to 18 carbon atoms (C), 10% by weight to 30% by weight of the (meth)acrylate having a urethane group (D), and 2% by weight to 10% by weight of the photopolymerization initiator (E); and a cured product obtained by curing the active energy ray-curable composition. Effect of the Invention
[0006] The active energy ray-curable composition of the present invention has an effect of having a low viscosity, and a cured product of the active energy ray-curable composition of the present invention has high elongation and a high elastic modulus. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0007] The active energy ray-curable composition of the present invention contains (A) a (meth)acrylate having an alicyclic skeleton, (B) an N-substituted (meth)acrylamide, (C) a monofunctional (meth)acrylate having a linear or branched alkyl group having 8 to 18 carbon atoms, (D) a (meth)acrylate having a urethane group, and (E) a photopolymerization initiator. In the present invention, the term "(meth)acrylate" means acrylate and / or methacrylate, the term "(meth)acrylic" means acrylic and / or methacrylic, and the term "(meth)acryloyl" means acryloyl and / or methacryloyl.
[0008] Examples of the (meth)acrylate (A) having an alicyclic skeleton include cyclohexyl (meth)acrylate, t-butylcyclohexyl (meth)acrylate, trimethylcyclohexyl (meth)acrylate, isobornyl (meth)acrylate, dicyclopentanyl (meth)acrylate, dicyclopentenyl (meth)acrylate, and adamantyl (meth)acrylate. Of the (meth)acrylates (A) having an alicyclic skeleton, from the viewpoint of elongation and elastic modulus of the cured product, preferred are monofunctional (meth)acrylates having an alicyclic skeleton, more preferred are monofunctional (meth)acrylates having an alicyclic skeleton having 6 to 30 carbon atoms, particularly preferred are monofunctional acrylates having an alicyclic skeleton having 6 to 30 carbon atoms, and most preferred are isobornyl acrylate, dicyclopentanyl acrylate, t-butylcyclohexyl acrylate and trimethylcyclohexyl acrylate.
[0009] In the present invention, the N-substituted (meth)acrylamide (B) means a (meth)acrylamide in which one or two hydrogen atoms of the amino group are substituted with a substituent such as a hydrocarbon group. Examples of the N-substituted (meth)acrylamide include a chain amide having an N-(meth)acryloyl group and a cyclic amide having an N-(meth)acryloyl group.
[0010] Examples of the chain amide having an N-(meth)acryloyl group include N-alkyl(meth)acrylamide, N,N-dialkyl(meth)acrylamide, N-hydroxyalkyl(meth)acrylamide, and N-alkoxyalkyl(meth)acrylamide.
[0011] Examples of N-alkyl(meth)acrylamides include N-methyl(meth)acrylamide, N-ethyl(meth)acrylamide, N-propyl(meth)acrylamide, N-isopropyl(meth)acrylamide, N-dodecyl(meth)acrylamide, and N-octadecyl(meth)acrylamide. The alkyl groups of the N-alkyl(meth)acrylamides may be the same or different, and the number of carbon atoms of the alkyl groups is preferably 1 to 20, more preferably 1 to 8, and particularly preferably 1 to 4, from the viewpoint of curability.
[0012] Examples of N,N-dialkyl(meth)acrylamides include N,N-dimethyl(meth)acrylamide, N,N-diethyl(meth)acrylamide, N,N-dipropyl(meth)acrylamide, N,N-diisopropyl(meth)acrylamide, N,N-dibutyl(meth)acrylamide, N,N-diisobutyl(meth)acrylamide, N,N-di-tert-butyl(meth)acrylamide, N,N-diheptyl(meth)acrylamide, N,N-dioctyl(meth)acrylamide, N,N-di-tert-octyl(meth)acrylamide, N,N-didodecyl(meth)acrylamide, and N,N-dioctadecyl(meth)acrylamide. The two alkyl groups of N,N-dialkyl(meth)acrylamide may be the same or different, and the number of carbon atoms of the alkyl group is preferably 1 to 20, more preferably 1 to 8, and particularly preferably 1 to 4, from the viewpoint of curability.
[0013] Examples of N-hydroxyalkyl(meth)acrylamide include N-hydroxymethyl(meth)acrylamide, N-hydroxyethyl(meth)acrylamide, and N-(3-hydroxypropyl)(meth)acrylamide. From the viewpoint of curability, the number of carbon atoms in the alkyl group of the N-hydroxyalkyl(meth)acrylamide is preferably 1 to 20, more preferably 1 to 8, and particularly preferably 1 to 4.
[0014] Examples of N-alkoxyalkyl(meth)acrylamides include Nn-butoxymethyl(meth)acrylamide, N-methoxymethyl(meth)acrylamide, N-ethoxymethyl(meth)acrylamide, N-propoxymethyl(meth)acrylamide, N-butoxymethyl(meth)acrylamide, N-methoxyethyl(meth)acrylamide, N-ethoxyethyl(meth)acrylamide, N-butoxyethyl(meth)acrylamide, N-methoxypropyl(meth)acrylamide, N-ethoxypropyl(meth)acrylamide, N-methoxybutyl(meth)acrylamide, and N-ethoxybutyl(meth)acrylamide. The number of carbon atoms in the alkoxyalkyl group of the N-alkoxyalkyl(meth)acrylamide is preferably 2 to 20, more preferably 2 to 8, and particularly preferably 2 to 6, from the viewpoint of curability. The number of carbon atoms in the alkyl group of the alkoxyalkyl group is preferably 1 to 4, more preferably 1 to 3, and particularly preferably 1 to 2, from the viewpoint of curability.
[0015] Examples of the cyclic amide having an N-(meth)acryloyl group include N-(meth)acryloylmorpholine, N-(meth)acryloylthiomorpholine, N-(meth)acryloylpiperidine, and N-(meth)acryloylpyrrolidine. The number of carbon atoms in the cyclic amide having an N-(meth)acryloyl group is preferably 7 to 20, more preferably 7 to 18, and particularly preferably 7 to 16, from the viewpoint of curability. In the present invention, these N-substituted (meth)acrylamides can be used alone or in combination of two or more. Among these, from the viewpoint of curability, preferred are N,N-dialkyl(meth)acrylamides, N-alkoxyalkyl(meth)acrylamides, and cyclic amides having an N-(meth)acryloyl group, more preferred are N,N-dialkyl(meth)acrylamides and cyclic amides having an N-(meth)acryloyl group, and particularly preferred are N,N-dimethyl(meth)acrylamide, N,N-diethyl(meth)acrylamide, and N-(meth)acryloylmorpholine.
[0016] Examples of the monofunctional (meth)acrylate (C) having a straight-chain or branched alkyl group having 8 to 18 carbon atoms include octyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, nonyl (meth)acrylate, decyl (meth)acrylate, isodecyl (meth)acrylate, undecyl (meth)acrylate, lauryl (meth)acrylate, tridecyl (meth)acrylate, stearyl (meth)acrylate, and isostearyl (meth)acrylate. These (meth)acrylates can be easily produced by direct esterification or transesterification of (meth)acrylic acid or methyl (meth)acrylate with natural or synthetic alcohol. If natural alcohol is used, the alkyl group will be straight-chain and have an even carbon number. If synthetic alcohol, for example Dobanol (manufactured by Mitsubishi Petrochemicals), is used, the alkyl group will be a mixture of straight-chain and branched, and the number of carbon atoms will be a mixture of odd and even. When Diadol (manufactured by Mitsubishi Chemical) is used, the alkyl groups are a mixture of straight and branched chains, and only odd-numbered carbon atoms are available. Among the monofunctional (meth)acrylates (C) having a linear or branched alkyl group having 8 to 18 carbon atoms, from the viewpoint of the elongation and elastic modulus of the cured product, preferred are monofunctional alkyl (meth)acrylates having a linear or branched alkyl group having 8 to 18 carbon atoms, and more preferred are octyl (meth)acrylate, isodecyl (meth)acrylate, lauryl (meth)acrylate, stearyl (meth)acrylate and isostearyl (meth)acrylate. The above-mentioned (C) may be used alone or in combination of two or more kinds.
[0017] The (meth)acrylate (D) having a urethane group is a urethane (meth)acrylate containing polyol (a), polyisocyanate (b) and active hydrogen group-containing (meth)acrylate (c) as constituent materials. The (meth)acrylate (D) having a urethane group is preferably a urethane (meth)acrylate having 1 to 2 (meth)acryloyl groups, from the viewpoint of elongation of the cured product.
[0018] Examples of the polyol (a) include linear aliphatic polyols (a1) having 2 to 20 carbon atoms, alicyclic polyols (a2) having 6 to 20 carbon atoms, and aromatic polyols (a3) having 6 to 20 carbon atoms, as well as their alkylene oxide adducts (ethylene oxide (hereinafter, "ethylene oxide" may be abbreviated as EO), 1,2- or 1,3-propylene oxide (hereinafter, "1,2-propylene oxide" may be abbreviated as PO), and 1,2-, 1,3-, 1,4-, or 2,3-butylene oxide, etc.).
[0019] Examples of the chain aliphatic polyol (a1) having 2 to 20 carbon atoms include linear aliphatic diols having 2 to 20 carbon atoms (ethylene glycol, 1,3-propylene glycol, 1,4-butanediol, 1,5-pentanediol, 1,6-hexanediol, 1,7-heptanediol, 1,8-octanediol, 1,9-nonanediol, and 1,10-dodecanediol), branched aliphatic diols (1,2-propylene glycol, 1 , 2-, 1,3- or 2,3-butanediol, 2-methyl-1,4-butanediol, neopentyl glycol, 2,2-diethyl-1,3-propanediol, 2-methyl-1,5-pentanediol, 3-methyl-1,5-pentanediol, etc.) and chain aliphatic trihydric to octahydric alcohols (pentaerythritol, sorbitol, mannitol, sorbitan, diglycerin, dipentaerythritol, etc.).
[0020] Examples of the alicyclic polyol (a2) having 6 to 20 carbon atoms include 1,2-cyclohexanediol, 1,3-cyclohexanedimethanol, 1,4-cyclohexanediol, 1,3-cyclopentanediol, 1,4-cycloheptanediol, 1,4-bis(hydroxymethyl)cyclohexane, 2,2-bis(4-hydroxycyclohexyl)propane, and 1,3,5-cyclohexanetriol.
[0021] Examples of the aromatic polyol (a3) having 6 to 20 carbon atoms include resorcinol, hydroquinone, naphthalene diol, and bisphenols (such as bisphenol A, bisphenol F, and bisphenol S).
[0022] When an alkylene oxide adduct of the chain aliphatic polyol (a1), the alicyclic polyol (a2), or the aromatic polyol (a3) is used as the polyol (a), the number of moles of the alkylene oxide added is preferably 1 to 50 moles, more preferably 4 to 30 moles, from the viewpoint of elongation of the cured product.
[0023] Among these polyols (a), from the viewpoint of elongation of the cured product, preferred are the alkylene oxide adducts of the chain aliphatic polyol (a1) having 2 to 20 carbon atoms, the alkylene oxide adducts of the alicyclic polyol (a2) having 6 to 20 carbon atoms, and the alkylene oxide adducts of the aromatic polyol (a3) having 6 to 20 carbon atoms, more preferred are the alkylene oxide adducts of the chain aliphatic polyol (a1), particularly preferred are the 1,4-butylene oxide adducts of the chain aliphatic polyol (a1) and the 1,2-propylene oxide adducts of the chain aliphatic polyol (a1), and most preferred are poly-1,4-butylene oxide (polytetramethylene glycol) and poly-1,2-propylene oxide (polypropylene glycol). The polyol (a) may be used alone or in combination of two or more kinds.
[0024] Examples of the polyisocyanate (b) include chain aliphatic polyisocyanates (b1) having 4 to 20 carbon atoms, alicyclic polyisocyanates (b2) having 6 to 22 carbon atoms, and aromatic polyisocyanates (b3) having 8 to 22 carbon atoms.
[0025] Examples of the chain aliphatic polyisocyanate (b1) having 4 to 20 carbon atoms include ethylene diisocyanate, tetramethylene diisocyanate, hexamethylene diisocyanate (HDI), dodecamethylene diisocyanate, 2,2,4-trimethylhexamethylene diisocyanate, and lysine diisocyanate.
[0026] Examples of the alicyclic polyisocyanate (b2) having 6 to 22 carbon atoms include cyclohexane-1,3-diylbismethylene diisocyanate, isophorone diisocyanate (IPDI), 2,4- or 2,6-methylcyclohexane diisocyanate (hydrogenated TDI), dicyclohexylmethane-4,4'-diisocyanate (hydrogenated MDI. hereinafter, sometimes referred to as MDIH), cyclohexylene diisocyanate, methylcyclohexylene diisocyanate, bis(2-isocyanatoethyl)-4-cyclohexylene-1,2-dicarboxylate, 2,5- or 2,6-norbornane diisocyanate, and dimer acid diisocyanate.
[0027] Examples of the aromatic polyisocyanate (b3) having 8 to 22 carbon atoms include 1,3- or 1,4-phenylene diisocyanate, 2,4- or 2,6-tolylene diisocyanate (TDI), 4,4'- or 2,4'-diphenylmethane diisocyanate (MDI), m- or p-isocyanatophenylsulfonyl isocyanate, 4,4'-diisocyanatobiphenyl, 3,3'-dimethyl-4,4'-diisocyanatobiphenyl, 3,3'-dimethyl-4,4'-diisocyanatodiphenylmethane, 1,5-naphthylene diisocyanate, m- or p-isocyanatophenylsulfonyl isocyanate, m- or p-xylylene diisocyanate (XDI), and α,α,α',α'-tetramethylxylylene diisocyanate (TMXDI).
[0028] Of these polyisocyanates (b), from the viewpoint of elongation and light resistance of the cured product, preferred are alicyclic polyisocyanates (b2) having 6 to 22 carbon atoms and aromatic polyisocyanates (b3) having 8 to 22 carbon atoms, more preferred are alicyclic polyisocyanates having 6 to 20 carbon atoms and aromatic polyisocyanates having 8 to 20 carbon atoms, particularly preferred are cyclohexane-1,3-diylbismethylene diisocyanate, IPDI, XDI, TMXDI, MDI and TDI, and most preferred is IPDI. The polyisocyanate (b) may be used alone or in combination of two or more kinds.
[0029] Examples of the active hydrogen group-containing (meth)acrylate (c) include hydroxyl group-containing (meth)acrylate (c1), amino group-containing (meth)acrylate (c2) and carboxyl group-containing (meth)acrylate (c3). Among these, preferred is hydroxyl group-containing (meth)acrylate. Examples of the hydroxyl group-containing (meth)acrylate (c1) include hydroxyalkyl (meth)acrylate (c11) and polyalkylene glycol mono(meth)acrylate (c12).
[0030] The hydroxyalkyl (meth)acrylate (c11) preferably includes a hydroxyalkyl (meth)acrylate having 4 to 20 carbon atoms, and specific examples thereof include 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, and 3-hydroxypropyl (meth)acrylate.
[0031] Examples of the polyalkylene glycol mono(meth)acrylate (c12) include polyethylene glycol mono(meth)acrylate and polypropylene glycol mono(meth)acrylate.
[0032] Examples of the amino group-containing (meth)acrylate (c2) include monoalkyl (carbon number 1 to 4) aminoalkyl (carbon number 2 to 6) (meth)acrylates {aminoethyl, aminopropyl, methylaminoethyl, ethylaminoethyl, butylaminoethyl, or methylaminopropyl (meth)acrylate} and dialkyl (carbon number 1 to 4) aminoalkyl (carbon number 2 to 6) (meth)acrylates {dimethylaminoethyl (meth)acrylate, diethylaminoethyl (meth)acrylate, dibutylaminoethyl (meth)acrylate, etc.}.
[0033] Examples of the carboxyl group-containing (meth)acrylate (c3) include 2-(meth)acryloyloxyethyl succinic acid, 2-(meth)acryloyloxyethyl phthalic acid, and 2-(meth)acryloyloxyethyl hexahydrophthalic acid.
[0034] Of the active hydrogen group-containing (meth)acrylates (c), from the viewpoints of reactivity in the urethane reaction and elongation of the cured product, preferred are hydroxyl group-containing (meth)acrylates (c1), more preferred are hydroxyl group-containing monofunctional (meth)acrylates, particularly preferred are hydroxyalkyl (meth)acrylates (c11), and most preferred is 2-hydroxyethyl (meth)acrylate. The active hydrogen group-containing (meth)acrylate (c) may be used alone or in combination of two or more kinds. The (meth)acrylate (D) having a urethane group may be used alone or in combination of two or more kinds.
[0035] With regard to the polyol (a), polyisocyanate (b) and active hydrogen group-containing (meth)acrylate (c), which are the constituent raw materials of the (meth)acrylate (D) having a urethane group, the molar ratio of the isocyanate groups in the polyisocyanate (b) to the active hydrogen groups in the polyol (a) and the active hydrogen group-containing (meth)acrylate (c) [isocyanate groups in (b) / total of active hydrogen groups in (a) and active hydrogen groups in (c)] is not particularly limited, but is preferably 1 / 0.5 to 1 / 10, more preferably 1 / 0.7 to 1 / 5, and particularly preferably 1 / 1 to 1 / 2, from the viewpoint of storage stability.
[0036] The number average molecular weight (hereinafter sometimes abbreviated as Mn) of the (meth)acrylate (D) having a urethane group is preferably from 500 to 50,000, more preferably from 700 to 20,000, and particularly preferably from 1000 to 10,000.
[0037] In the present invention, Mn can be measured by gel permeation chromatography (GPC) under the following conditions. Apparatus: "Waters Alliance 2695" [Waters] Column: "Guardcolumn Super HL" (1 piece), "TSKgel A combination of one each of SuperH2000, TSKgel SuperH3000, and TSKgel SuperH4000 (all manufactured by Tosoh Corporation) Sample solution: 0.25% by weight tetrahydrofuran solution Solution injection volume: 10μl Flow rate: 0.6ml / min Measurement temperature: 40℃ Detector: Refractive index detector Reference material: Standard polyethylene glycol
[0038] The (meth)acrylate (D) having a urethane group in the present invention can be produced by reacting a polyol (a), a polyisocyanate (b) and an active hydrogen group-containing (meth)acrylate (c) by a known method. Among these, it is preferable to carry out a polyaddition reaction between (a) and (b) to produce a urethane prepolymer having two or more isocyanate groups, and then carry out an addition reaction with (c). In the above polyaddition reaction and addition reaction, a urethanization catalyst may be used. Examples of the urethanization catalyst include metal compounds (organobismuth compounds, organotin compounds, organotitanium compounds, etc.) and quaternary ammonium salts.
[0039] The active energy ray-curable composition of the present invention may contain an ethylenically unsaturated monomer other than the (meth)acrylate (A) having an alicyclic skeleton, the N-substituted (meth)acrylamide (B), the monofunctional (meth)acrylate (C) having a linear or branched alkyl group having 8 to 18 carbon atoms, and the (meth)acrylate (D) having a urethane group. Examples of the other ethylenically unsaturated monomers include monofunctional ethylenically unsaturated monomers, difunctional ethylenically unsaturated monomers, and trifunctional or higher ethylenically unsaturated monomers.
[0040] [Monofunctional ethylenically unsaturated monomers] Examples of the monofunctional ethylenically unsaturated monomer include methyl (meth)acrylate, ethyl (meth)acrylate, butyl (meth)acrylate, tert-butyl (meth)acrylate, hexyl (meth)acrylate, isoamyl (meth)acrylate, benzyl (meth)acrylate, phenoxyethyl (meth)acrylate, tetrahydrofurfuryl (meth)acrylate, 2-methyl-2-ethyl-1,3-dioxolan-4-yl)methyl acrylate, 5-ethyl-1,3-dioxan-5-ylmethyl acrylate, 2-ethylhexyl diglycol (meth)acrylate, 2-chloroethyl (meth)acrylate, 4-bromobutyl (meth)acrylate, 2-ethylhexyl carbitol (meth)acrylate, 2,2,2-tetrafluoroethyl (meth)acrylate, 1H,1H,2H,2H-perfluorodecyl ... (meth)acrylate, 4-butylphenyl (meth)acrylate, phenyl (meth)acrylate, 2,4,5-tetramethylphenyl (meth)acrylate, 4-chlorophenyl (meth)acrylate, phenoxymethyl (meth)acrylate, phenoxyethyl (meth)acrylate, glycidyl (meth)acrylate, glycidyloxybutyl (meth)acrylate, glycidyloxyethyl (meth)acrylate, glycidyloxypropyl (meth)acrylate, trimethoxysilylpropyl (meth)acrylate, trimethoxysilylpropyl (meth)acrylate, trimethylsilylpropyl (meth)acrylate, trifluoroethyl (meth)acrylate, perfluorooctylethyl (meth)acrylate, N-vinylpyrrolidone, N-vinylcaprolactone, and 3-vinyl-5-methyl-2-oxazolidinone.
[0041] The difunctional ethylenically unsaturated monomer includes a difunctional (meth)acrylate monomer.
[0042] [Bifunctional (meth)acrylate monomer] Examples of the bifunctional (meth)acrylate monomer include 1,6-hexanediol di(meth)acrylate, 1,10-decanediol di(meth)acrylate, neopentyl glycol di(meth)acrylate, 2,4-dimethyl-1,5-pentanediol di(meth)acrylate, 2-ethyl-2-butyl-butanediol di(meth)acrylate, 1,4-butanediol di(meth)acrylate, 2-ethyl-2-butyl-propanediol di(meth)acrylate, 1,9-nonanediol di(meth)acrylate, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, acrylate, tetraethylene glycol di(meth)acrylate, polyethylene glycol #200 di(meth)acrylate (#200 means number average molecular weight 200, same below), polyethylene glycol #300 di(meth)acrylate, polyethylene glycol #400 di(meth)acrylate, polyethylene glycol #600 di(meth)acrylate, dipropylene glycol di(meth)acrylate, tripropylene glycol di(meth)acrylate, tetrapropylene glycol di(meth)acrylate, polypropylene glycol #400 di(meth)acrylate, and polypropylene glycol #700 di(meth)acrylate.
[0043] Examples of the tri- or higher functional ethylenically unsaturated monomer include trifunctional (meth)acrylate monomers and tetrafunctional or higher functional (meth)acrylate monomers.
[0044] [Trifunctional (meth)acrylate monomer] Examples of the monomer include trimethylolethane tri(meth)acrylate, trimethylolpropane tri(meth)acrylate, modified tri(meth)acrylate of an alkylene oxide adduct having 3 to 4 carbon atoms to trimethylolpropane, pentaerythritol tri(meth)acrylate, dipentaerythritol tri(meth)acrylate, trimethylolpropane tri((meth)acryloyloxypropyl)ether, sorbitol tri(meth)acrylate, tri(meth)acrylate of an alkylene oxide adduct having 1 to 30 moles of an alkylene oxide having 3 to 4 carbon atoms to pentaerythritol, and ethoxylated glycerin tri(meth)acrylate.
[0045] [Four or more functional (meth)acrylate monomers] Examples of the tetrafunctional or higher (meth)acrylate monomer include pentaerythritol tetra(meth)acrylate, sorbitol tetra(meth)acrylate, ditrimethylolpropane tetra(meth)acrylate, dipentaerythritol tetra(meth)acrylate, dipentaerythritol propionate tetra(meth)acrylate, tetra(meth)acrylate of an adduct of pentaerythritol with 1 to 11 moles of an alkylene oxide having 3 to 4 carbon atoms, sorbitol penta(meth)acrylate, dipentaerythritol penta(meth)acrylate, dipentaerythritol hexa(meth)acrylate, sorbitol hexa(meth)acrylate, and caprolactone-modified dipentaerythritol hexa(meth)acrylate.
[0046] Examples of the photopolymerization initiator (E) include benzoin compounds (E-1), alkylphenone compounds (E-2), anthraquinone compounds (E-3), thioxanthone compounds (E-4), benzophenone compounds (E-5), phosphine oxides (E-6), and oxime ester compounds (E-7).
[0047] Examples of the benzoin compound (E-1) include benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin propyl ether, and benzoin isobutyl ether.
[0048] Examples of the alkylphenone compound (E-2) include acetophenone, α-hydroxyalkylphenone acetophenone, (2-hydroxy-2-methyl-phenylpropan-1-one, 1-hydroxycyclohexyl phenyl ketone, etc.), α-aminoalkylphenone [2-methyl-1-[4-(methylthio)phenyl]-2-morpholinopropan-1-one, 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(4-morpholinyl)phenyl]-1-butanone, etc.], acetophenone dimethyl ketal, benzyl dimethyl ketal, 2,2-diethoxy-2-phenylacetophenone, 2,2-diethoxy-2-phenylacetophenone, 1,1-dichloroacetophenone, and diethoxyacetophenone.
[0049] Examples of the anthraquinone compound (E-3) include 2-ethylanthraquinone, 2-t-butylanthraquinone, 2-chloroanthraquinone, and 2-amylanthraquinone.
[0050] Examples of the thioxanthone compound (E-4) include 2,4-diethylthioxanthone, 2-isopropylthioxanthone, and 2-chlorothioxanthone.
[0051] Examples of the benzophenone compound (E-5) include benzophenone, 4-benzoyl-4'-methyldiphenyl sulfide, and 4,4'-bismethylaminobenzophenone.
[0052] Examples of the phosphine oxide (E-6) include 2,4,6-trimethylbenzoyl-diphenylphosphine oxide, bis-(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphine oxide, and bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide.
[0053] Examples of the oxime ester compound (E-7) include 1-[4-(phenylthio)phenyl]-1,2-octanedione 2-(O-benzoyloxime) and ethanone-1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazol-3-yl]-1-(O-acetyloxime).
[0054] Among the photopolymerization initiators (E), from the viewpoint of curability, preferred are the alkylphenone compounds (E-2) and the phosphine oxides (E-6), more preferred are the alkylphenone compounds (E-2), and particularly preferred are α-hydroxyalkylphenones, acetophenones and α-aminoalkylphenones. The photopolymerization initiator (E) may be used alone or in combination of two or more kinds.
[0055] The active energy ray-curable composition of the present invention may contain other additives in addition to the above-mentioned (A) to (E) and other ethylenically unsaturated monomers. Other additives include slip agents (F) and polymerization inhibitors (G).
[0056] Slip agents (F) include silicone slip agents (F1) and fluorine slip agents (F2), etc. (F) may also contain radically polymerizable reactive groups.
[0057] The silicone slip agent (F1) may be an alkylene oxide (hereinafter abbreviated as AO) modified polydialkylsiloxane, etc. The AO modified polydialkylsiloxane may be an AO modified polydialkylsiloxane (F11) whose terminal is modified with AO, or an AO modified polydialkylsiloxane (F12) whose side chain is modified with AO. The polydialkylsiloxane (F11) and the polydialkylsiloxane (F12) may be further modified with (meth)acryloyl.
[0058] Examples of the polydialkylsiloxane (F11) include polydimethylsiloxane having terminals modified with EO, polydimethylsiloxane having terminals modified with EO and PO, polydiethylsiloxane having terminals modified with EO, and (meth)acrylates thereof.
[0059] Examples of the polydialkylsiloxane (F12) include polydimethylsiloxane whose side chain is modified with PO, polydimethylsiloxane whose side chain is modified with EO and butylene oxide, polydimethylsiloxane whose side chain is modified with EO and PO, and (meth)acrylates thereof.
[0060] Of these silicone slip agents (F1), the above-mentioned polydialkylsiloxanes (F12) are preferred from the standpoint of coatability, and polydimethylsiloxanes whose side chains have been modified with EO and PO are even more preferred.
[0061] The fluorine slip agent (F2) may be a perfluoroalkyl ethylene oxide adduct, etc. Examples of the perfluoroalkyl ethylene oxide adduct include perfluoro compounds (F21) whose terminals are modified with alkylene oxide, and perfluoro compounds (F22) whose side chains are modified with alkylene oxide. The perfluoro compound (F21) and the perfluoro compound (F22) may be further modified with (meth)acryloyl.
[0062] The Mn of the slip agent (F) is preferably 300 to 50,000. The slip agent (F) may be used alone or in combination of two or more kinds.
[0063] Examples of the polymerization inhibitor (G) include phenol compounds [hydroquinone, 4-methoxyphenol, 2,6-di-t-butyl-p-cresol, 2,2-methylene-bis-(4-methyl-6-t-butylphenol), 1,1,3-tris-(2-methyl-4-hydroxy-5-t-butylphenyl)butane, etc.], sulfur compounds (dilauryl thiodipropionate, etc.), phosphorus compounds (triphenyl phosphite, etc.), and amine compounds (phenothiazine, etc.). The polymerization inhibitor (G) may be used alone or in combination of two or more kinds.
[0064] The weight proportion of the (meth)acrylate (A) having an alicyclic skeleton of the present invention is 20 to 70% by weight, preferably 30 to 70% by weight, and more preferably 40 to 70% by weight, based on the total weight of the (meth)acrylate (A) having an alicyclic skeleton, the N-substituted (meth)acrylamide (B), the monofunctional (meth)acrylate (C) having a linear or branched alkyl group having 8 to 18 carbon atoms, and the (meth)acrylate (D) having a urethane group. If the weight proportion of (A) is less than 20% by weight, the elastic modulus of the cured product will be insufficient, and if it exceeds 70% by weight, the elongation of the cured product will be insufficient.
[0065] The weight proportion of the N-substituted (meth)acrylamide (B) of the present invention is 10 to 40% by weight, preferably 10 to 30% by weight, and more preferably 10 to 25% by weight, based on the total weight of the (meth)acrylate (A) having an alicyclic skeleton, the N-substituted (meth)acrylamide (B), the monofunctional (meth)acrylate (C) having a linear or branched alkyl group having 8 to 18 carbon atoms, and the (meth)acrylate (D) having a urethane group. If the weight proportion of (B) is less than 10% by weight, the cured product will have insufficient elongation, whereas if it exceeds 40% by weight, the cured product will have insufficient elastic modulus.
[0066] The weight proportion of the monofunctional (meth)acrylate (C) having a linear or branched alkyl group having 8 to 18 carbon atoms of the present invention is 2 to 20% by weight, preferably 4 to 15% by weight, and more preferably 5 to 13% by weight, based on the total weight of the (meth)acrylate (A) having an alicyclic skeleton, the N-substituted (meth)acrylamide (B), the monofunctional (meth)acrylate (C) having a linear or branched alkyl group having 8 to 18 carbon atoms, and the (meth)acrylate (D) having a urethane group. If the weight proportion of (C) is less than 2% by weight, the cured product will have insufficient elongation, whereas if it exceeds 20% by weight, the cured product will have insufficient elastic modulus.
[0067] The weight proportion of the (meth)acrylate (D) having a urethane group of the present invention is 10 to 30% by weight, preferably 12 to 28% by weight, and more preferably 13 to 25% by weight, based on the total weight of the (meth)acrylate (A) having an alicyclic skeleton, the N-substituted (meth)acrylamide (B), the monofunctional (meth)acrylate (C) having a linear or branched alkyl group having 8 to 18 carbon atoms, and the (meth)acrylate (D) having a urethane group. If the weight proportion of (D) is less than 10% by weight, the elastic modulus of the cured product will be insufficient, whereas if it exceeds 30% by weight, the viscosity will be too high and handling properties will be insufficient.
[0068] The weight proportion of the photopolymerization initiator (E) of the present invention is 2 to 10% by weight, preferably 2.5 to 8% by weight, and more preferably 3 to 6% by weight, based on the total weight of the (meth)acrylate having an alicyclic skeleton (A), the N-substituted (meth)acrylamide (B), the monofunctional (meth)acrylate having a linear or branched alkyl group having 8 to 18 carbon atoms (C), and the (meth)acrylate having a urethane group (D). If the weight ratio of (E) is less than 2% by weight, the tensile modulus is insufficient, and if it exceeds 10% by weight, the elongation is insufficient.
[0069] In the present invention, when the slip agent (F) is used, the weight proportion of the slip agent (F) is preferably 0.01 to 5% by weight, and more preferably 0.1 to 3% by weight, based on the total weight of the (meth)acrylate having an alicyclic skeleton (A), the N-substituted (meth)acrylamide (B), the monofunctional (meth)acrylate having a linear or branched alkyl group having 8 to 18 carbon atoms (C), and the (meth)acrylate having a urethane group, from the viewpoint of coatability of the active energy ray-curable composition. In the present invention, when the polymerization inhibitor (G) is used, the weight proportion of the polymerization inhibitor (G) is preferably 0.01 to 5% by weight, and more preferably 0.05 to 3% by weight, based on the total weight of the (meth)acrylate having an alicyclic skeleton (A), the N-substituted (meth)acrylamide (B), the monofunctional (meth)acrylate having a linear or branched alkyl group having 8 to 18 carbon atoms (C), and the (meth)acrylate having a urethane group, from the viewpoints of the storage stability and polymerization rate of the active energy ray-curable composition.
[0070] The method for producing the active energy ray-curable composition of the present invention is not particularly limited. For example, the composition can be produced by uniformly mixing the monofunctional (meth)acrylate having an alicyclic skeleton (A), the N-substituted (meth)acrylamide (B), the monofunctional (meth)acrylate having a linear or branched alkyl group having 8 to 18 carbon atoms (C), the (meth)acrylate having a urethane group (D), and the photopolymerization initiator (E), as well as other ethylenically unsaturated monomers and other additives, if necessary, in a temperature range of 20 to 80° C. by using a known mechanical mixing method (a method using a mechanical stirrer, a magnetic stirrer, or the like).
[0071] The cured product of the present invention is a product of the curing of the active energy ray-curable composition. That is, the active energy ray-curable composition is cured by active energy rays to become a cured product. Examples of the active energy rays include ultraviolet rays and electron beams. When irradiating with the ultraviolet light, a known ultraviolet light irradiation device equipped with a high pressure mercury lamp, a metal halide lamp, etc. can be used. The irradiation amount of the ultraviolet light is preferably 10 to 10,000 mJ / cm from the viewpoints of curability and suppression of yellowing and deterioration. 2 and more preferably 100 to 5,000 mJ / cm 2 It is. When irradiating with the electron beam, a known electron beam irradiation device can be used. The irradiation dose of the electron beam is preferably 1 to 10 Mrad from the viewpoints of curability and suppression of deterioration of the cured product.
[0072] The cured product of the active energy ray-curable composition of the present invention has high elongation and high elastic modulus, and is therefore useful as a material for flexible displays. EXAMPLES
[0073] The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples. In the examples, GPC was measured under the following conditions. Apparatus: "Waters Alliance 2695" [Waters] Column: "Guardcolumn Super HL" (1 piece), "TSKgel A combination of one each of SuperH2000, TSKgel SuperH3000, and TSKgel SuperH4000 (all manufactured by Tosoh Corporation) Sample solution: 0.25% by weight tetrahydrofuran solution Solution injection volume: 10μl Flow rate: 0.6ml / min Measurement temperature: 40℃ Detector: Refractive index detector Reference material: Standard polyethylene glycol
[0074] Production Example 1 [Synthesis of (meth)acrylate (D-1) having a urethane group] A reaction vessel was charged with 412 parts by weight of polytetramethylene glycol [trade name "PTMG1000", manufactured by Mitsubishi Chemical Corporation, number average molecular weight: 1000], 182 parts by weight of isophorone diisocyanate (IPDI), and 0.2 parts by weight of a urethane catalyst [bismuth tri(2-ethylhexanoate) (2-ethylhexanoic acid 50% by weight solution), the same below.], and reacted at 110°C for 3 hours, after which 104 parts by weight of 2-hydroxyethyl acrylate was added, and reacted at 80°C for 6 hours to obtain a (meth)acrylate (D-1) having a urethane group. The number average molecular weight of (D-1) was 1700. The number of (meth)acryloyl groups in (D-1) was about 2.
[0075] Production Example 2 [Synthesis of (meth)acrylate (D-2) having a urethane group] A reaction vessel was charged with 191 parts by weight of polytetramethylene glycol [product name "PTMG850", manufactured by Mitsubishi Chemical Corporation, number average molecular weight: 850], 101 parts by weight of IPDI, and 0.3 parts by weight of a urethane catalyst, and reacted at 110°C for 3 hours, after which 58 parts by weight of 2-hydroxyethyl acrylate was added and reacted at 80°C for 6 hours to obtain a (meth)acrylate (D-2) having a urethane group. The number average molecular weight of (D-2) was 1600. The number of (meth)acryloyl groups in (D-2) was about 2.
[0076] Production Example 3 [Synthesis of (meth)acrylate (D-3) having a urethane group] A reaction vessel was charged with 337 parts by weight of polytetramethylene glycol [trade name "PTMG650", manufactured by Mitsubishi Chemical Corporation, number average molecular weight: 650], 230 parts of IPDI, and 0.1 parts by weight of a urethane catalyst, and reacted at 110°C for 4 hours. Thereafter, 132 parts by weight of 2-hydroxyethyl acrylate was added, and the mixture was reacted at 80°C for 8 hours to obtain a (meth)acrylate (D-3) having a urethane group. The number average molecular weight of (D-3) was 1350. The number of (meth)acryloyl groups in (D-3) was about 2.
[0077] Production Example 4 [Synthesis of (meth)acrylate (D-4) having a urethane group] A reaction vessel was charged with 259 parts by weight of polytetramethylene glycol [trade name "PTMG2000", manufactured by Mitsubishi Chemical Corporation, number average molecular weight: 2000], 57 parts by weight of IPDI, and 0.1 parts by weight of a urethane catalyst, and reacted at 110°C for 4 hours, after which 33 parts by weight of 2-hydroxyethyl acrylate was added and reacted at 80°C for 8 hours to obtain a (meth)acrylate (D-4) having a urethane group. The number average molecular weight of (D-4) was 2700. The number of (meth)acryloyl groups in (D-4) was about 2.
[0078] Production Example 5 [Synthesis of (meth)acrylate (D-5) having a urethane group] A reaction vessel was charged with 259 parts by weight of polypropylene glycol [trade name "Sannyx PP-1000", manufactured by Sanyo Chemical Industries, Ltd., number average molecular weight: 1000], 57 parts by weight of IPDI, and 0.1 parts by weight of a urethane catalyst, and reacted at 110°C for 4 hours. Thereafter, 71 parts by weight of 2-hydroxybutyl acrylate and 11 parts by weight of methanol were added, and the mixture was reacted at 80°C for 8 hours to obtain a (meth)acrylate (D-5) having a urethane group. The number average molecular weight of (D-5) was 1600. The number of (meth)acryloyl groups in (D-5) was about 1.2.
[0079] Production Example 6 [Synthesis of (meth)acrylate (D-6) having a urethane group] A reaction vessel was charged with 259 parts by weight of polypropylene glycol [product name "Sannyx PP-2000", manufactured by Sanyo Chemical Industries, Ltd., number average molecular weight: 2000], 57 parts by weight of IPDI, and 0.1 parts by weight of a urethane catalyst, and reacted at 110°C for 4 hours, after which 31 parts by weight of 2-hydroxyethyl acrylate was added and reacted at 80°C for 8 hours to obtain a (meth)acrylate (D-6) having a urethane group. The number average molecular weight of (D-6) was 2700. The number of (meth)acryloyl groups in (D-6) was about 2.
[0080] Examples 1 to 13 and Comparative Examples 1 to 6 The compositions (parts by weight) shown in Table 1 were mixed uniformly at 60° C. to obtain active energy ray-curable compositions of Examples and Comparative Examples.
[0081] [Table 1]
[0082] The symbols in Table 1 indicate the following: (A-1): Isobornyl acrylate [product name "Light Acrylate IBXA", manufactured by Kyoeisha Chemical Co., Ltd.] (A-2): Dicyclopentanyl acrylate [product name "FA-513AS", manufactured by Hitachi Chemical Co., Ltd.] (A-3): 4-t-Butylcyclohexyl acrylate [product name "TBCHA", manufactured by KJ Chemicals Co., Ltd.] (A-4): 3,3,5-trimethylcyclohexyl acrylate [product name "SR-420", manufactured by Arkema Co., Ltd.] (B-1): Dimethylacrylamide [product name "DMAA", manufactured by KJ Chemicals Co., Ltd.] (B-2): Diethylacrylamide [product name "DEAA", manufactured by KJ Chemicals Co., Ltd.] (B-3): Acryloylmorpholine [product name "ACMO", manufactured by KJ Chemicals Co., Ltd.] (C-1): normal octyl acrylate [product name "NOAA", manufactured by Osaka Organic Chemical Industry Co., Ltd.] (C-2): Isodecyl acrylate [product name "IDAA", manufactured by Osaka Organic Chemical Industry Co., Ltd.] (C-3): Lauryl acrylate [product name "LA", manufactured by Osaka Organic Chemical Industry Co., Ltd.] (C-4): Stearyl acrylate [product name "STA", manufactured by Osaka Organic Chemical Industry Co., Ltd.] (C-5): Isostearyl acrylate [product name "ISTA", manufactured by Osaka Organic Chemical Industry Co., Ltd.] (C'-1): t-butyl acrylate [product name "TBA", manufactured by Osaka Organic Chemical Industry Co., Ltd.] (C'-2): Behenyl acrylate [product name "Blenmer VA", manufactured by NOF Corporation] (E-1): 1-hydroxycyclohexyl phenyl ketone [product name: Omnirad184, manufactured by IGM Resins BV] (E-2): 2-methyl-1-[4-(methylthio)phenyl]-2-morpholinopropan-1-one [trade name: Omnirad907, manufactured by IGM Resins BV] (E-3): 2,4,6-trimethylbenzoyl-diphenylphosphine oxide [product name: Omnirad TPO, manufactured by IGM Resins BV] (F-1): Alkylene oxide modified polydimethylsiloxane [product name: BYK-333, manufactured by BYK Japan Co., Ltd.] (F-2): Perfluoroalkyl ethylene oxide adduct [product name: Megafac F-444, manufactured by DIC Corporation] (G-1): 4-Methoxyphenol [product name: MQ-F, manufactured by Kawaguchi Chemical Industry Co., Ltd.]
[0083] The viscosity of the active energy ray-curable compositions of Examples 1 to 13 and the comparative active energy ray-curable compositions of Comparative Examples 1 to 6, as well as the elongation and tensile modulus at room temperature (25°C) of each cured product obtained by curing the active energy ray-curable composition, were evaluated by the following methods. The results are shown in Table 1.
[0084] <Viscosity evaluation> The viscosity of the active energy ray-curable composition was measured using a viscosity measuring device [FUNGILAB's "Visco Elite B type"] at 25° C. A viscosity of 100 mPa·s or less is low viscosity and has good handleability.
[0085] <Preparation of test specimen> A PET film [product name: Lumirror S, Toray Industries, Inc.] was attached to a glass plate [product name: GLASS PLATE, AS ONE Corporation, 200 mm length × 200 mm width × 5 mm thickness], and an active energy ray curable composition was applied using an applicator so that the film thickness after curing would be 100 μm. UV rays were irradiated at 300 mJ / cm under a nitrogen atmosphere using an ultraviolet irradiation device [model number "VPS / I600", Fusion UV Systems, Inc.]. 2 By irradiation, a PET film covered with a cured product of the active energy ray-curable composition was obtained. The PET film coated with the above cured product was punched out into a dumbbell shape No. 3 in accordance with JIS K 6251:2017, and then the PET film was peeled off to obtain a test specimen for measurement.
[0086] <Tensile test> The obtained test specimen was allowed to stand at 25°C and 50% RH for 5 hours, and then the elongation was measured using an autograph [model number "AG-IS" (manufactured by Shimadzu Corporation)] in accordance with JIS K 6251:2017. In this case, the tensile test was performed with a chuck distance of 60 mm, a gauge length of 20 mm, and a tensile speed of 10 mm / min, and the elongation and tensile modulus were calculated using the following formulas.
[0087] <Elongation: Evaluation of elongation of cured material> Elongation (%) = (gauge length at break - gauge length) / (gauge length) x 100 <Tensile modulus: Evaluation of the modulus of elasticity of the cured product> Tensile modulus (MPa) = [Difference in test force (N) between two points: 1N and 3N points used] / [Difference in displacement (mm) between two points: 1N and 3N points used] × (gauge line distance: 20 mm) / (cross-sectional area of the dumbbell center part mm 2 )
[0088] From the results in Table 1, it is evident that the active energy ray-curable composition of the present invention has a low viscosity, and the cured product of the active energy ray-curable composition has excellent elongation and elastic modulus. On the other hand, the active energy ray-curable compositions of Comparative Examples 1 to 6 are insufficient in at least one of the following: viscosity, elongation percentage of the cured product, and elastic modulus of the cured product. [Industrial Applicability]
[0089] The cured product of the active energy ray-curable composition of the present invention has high elongation and high elastic modulus, and is therefore useful as a material for flexible displays.
Claims
1. An active energy ray-curable composition comprising: (A) a (meth)acrylate having an alicyclic skeleton; (B) an N-substituted (meth)acrylamide; (C) a monofunctional (meth)acrylate having a linear or branched alkyl group having 8 to 18 carbon atoms; (D) a (meth)acrylate having a urethane group; and (E) a photopolymerization initiator, the (meth)acrylate (D) having a urethane group is a urethane (meth)acrylate containing a polyol (a), a polyisocyanate (b), and an active hydrogen group-containing (meth)acrylate (c) as constituent raw materials and having one or two (meth)acryloyl groups; an active energy ray-curable composition, the content of the (meth)acrylate having an alicyclic skeleton (A) being 20% by weight to 70% by weight, the content of the N-substituted (meth)acrylamide (B) being 10% by weight to 40% by weight, the content of the monofunctional (meth)acrylate having a linear or branched alkyl group having 8 to 18 carbon atoms (C) being 2% by weight to 20% by weight, the content of the (meth)acrylate having a urethane group (D) being 10% by weight to 30% by weight, and the content of the photopolymerization initiator (E) being 2% by weight to 10% by weight, based on the total weight of the (meth)acrylate having an alicyclic skeleton (A), the N-substituted (meth)acrylamide (B), the monofunctional (meth)acrylate having a linear or branched alkyl group having 8 to 18 carbon atoms (C), and the (meth)acrylate having a urethane group (D).
2. The active energy ray-curable composition according to claim 1, wherein the (meth)acrylate (D) having a urethane group contains a polyol (a), isophorone diisocyanate, and an active hydrogen group-containing (meth)acrylate (c) as constituent raw materials, and the polyol (a) is at least one selected from the group consisting of a chain aliphatic polyol (a1) having 2 to 20 carbon atoms, an alicyclic polyol (a2) having 6 to 20 carbon atoms, an aromatic polyol (a3) having 6 to 20 carbon atoms, and an alkylene oxide adduct thereof.
3. The active energy ray-curable composition according to claim 1 or 2, wherein the (meth)acrylate (A) having an alicyclic skeleton is at least one monomer selected from the group consisting of isobornyl acrylate, dicyclopentanyl acrylate, t-butylcyclohexyl acrylate, and trimethylcyclohexyl acrylate.
4. The active energy ray-curable composition according to any one of claims 1 to 3, wherein the N-substituted (meth)acrylamide (B) is at least one monomer selected from the group consisting of (meth)acryloylmorpholine, diethyl(meth)acrylamide, and dimethyl(meth)acrylamide.
5. A cured product obtained by curing the active energy ray-curable composition according to any one of claims 1 to 4.
Citation Information
Patent Citations
Photocurable resin composition
JP2007161953A
Photocuring type composition for coating electrode
JP2010225322A
Electron beam curable composition for lens sheet support film formation, lens sheet support film, and lens sheet
JP2012194212A
Optical film- or sheet-forming active energy ray-curing composition, optical film or sheet, polarizer protective film and polarization plate
JP2013133427A
Liquid curable resin composition, image display device, and method for manufacturing image display device
JP2015040229A
